Non Steroidal Anti Inflammatory Drugs As Gatekeepers Of Colon Carcinoma Highlight New Scenarios Beyond Cyclooxygenases Inhibition

Author(s): Tiziana Guarnieri

Journal Name: Current Cancer Drug Targets

Volume 16 , Issue 2 , 2016

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


Epidemiological data suggest that Non Steroidal Anti Inflammatory Drugs (NSAIDs) and Cyclooxygenase 2 (COX2) inhibitors (COXibs) can exert chemopreventive and antitumour effects in many human neoplasia. This is particularly true in colon cancer (CC), where the regular assumption of these molecules has been shown to exert chemopreventive and chemotherapeutic effects. Since the late ‘90s, there has been a progressive increase in experimental evidence, indicating that in CC the antiproliferative effects of NSAIDs and COXibs could be both dependent on and independent of COXs inhibition, and that these effects do not necessarily exclude each other. This review will examine some of these COX-independent cellular pathways, with a focus on those involved in the inhibition of CC cells proliferation through transcription factors crosstalk.

Keywords: Colon carcinoma, inflammation, non steroidal anti inflammatory drugs, proliferation, transcription factor, tumour.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 26 August, 2015
Page: [186 - 197]
Pages: 12
DOI: 10.2174/1568009615666150827093012
Price: $65

Article Metrics

PDF: 39
PRC: 1